Atossa Therapeutics (ATOS) Assets (2011 - 2026)
Atossa Therapeutics (ATOS) posted quarterly Assets of $37.9 million for Q1 2026, down 46.37% year-over-year from $70.7 million in Q1 2025, and down 20.3% quarter-over-quarter from $47.6 million in Q4 2025.
Atossa Therapeutics (ATOS) Assets (2011 - 2026) Analysis & Trends
Atossa Therapeutics (ATOS) has reported Assets for 16 consecutive years, with $37.9 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Assets fell 46.37% year-over-year to $37.9 million; the TTM figure through Mar 2026 stood at $37.9 million (down 46.37% YoY), while the FY2025 annual figure was $47.6 million, down 37.72% from the prior year.
- Assets declined to $37.9 million in Q1 2026 per ATOS's latest filing, from $47.6 million in the prior quarter.
- Across five years, Assets topped out at $137.5 million in Q1 2022 and bottomed at $37.9 million in Q1 2026.
- Historically, Assets has averaged $91.5 million across 5 years, with a median of $91.1 million in 2024.
- Annual changes were most pronounced in 2022 — Assets decreased 2.55% — and 2026, when it sank 46.37%.
- Atossa Therapeutics' Assets stood at $123.5 million in 2022, then fell by 22.08% to $96.3 million in 2023, then fell by 20.58% to $76.4 million in 2024, then sank by 37.72% to $47.6 million in 2025, then retreated by 20.3% to $37.9 million in 2026.
- Business Quant data shows ATOS's Assets at $37.9 million in Q1 2026, $47.6 million in Q4 2025, and $58.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 27.42 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 41.73 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 10.03 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 10.96 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 9.18 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 5.56 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 25.60 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 2.10 Bn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 19.82 Bn |
| 10 | Atossa Therapeutics | 22.63 Mn | 22.63 Mn | - | 32.28 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 32.28 Mn |
| Mar 31, 2026 | 37.94 Mn |
| Dec 31, 2025 | 47.61 Mn |
| Sep 30, 2025 | 58.01 Mn |
| Jun 30, 2025 | 64.52 Mn |
| Mar 31, 2025 | 70.75 Mn |
| Dec 31, 2024 | 76.44 Mn |
| Sep 30, 2024 | 79.48 Mn |
| Jun 30, 2024 | 85.86 Mn |
| Mar 31, 2024 | 91.09 Mn |
| Dec 31, 2023 | 96.25 Mn |
| Sep 30, 2023 | 101.70 Mn |
| Jun 30, 2023 | 108.36 Mn |
| Mar 31, 2023 | 116.20 Mn |
| Dec 31, 2022 | 123.53 Mn |
| Sep 30, 2022 | 126.72 Mn |
| Jun 30, 2022 | 134.05 Mn |
| Mar 31, 2022 | 137.48 Mn |
| Dec 31, 2021 | 141.26 Mn |
| Sep 30, 2021 | 143.02 Mn |